Bain Capital Specialty Finance (BCSF) Cash & Equivalents (2021 - 2026)

Bain Capital Specialty Finance's Cash & Equivalents history runs 6 years deep, the most recent figure standing at $13.6 million for Q1 2026.

• In Q1 2026, Cash & Equivalents rose 33.66% year-over-year to $13.6 million; the TTM figure through Mar 2026 stood at $13.6 million (up 33.66% YoY), while the FY2025 annual figure was $38.8 million, down 62.53% from the prior year.
• Cash & Equivalents was $13.6 million for Q1 2026 at Bain Capital Specialty Finance, down from $38.8 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $128.6 million in Q2 2023 to a low of $10.2 million in Q1 2025.
• Historically, Cash & Equivalents has averaged $57.7 million across 5 years, with a median of $40.9 million in 2025.
• The sharpest annual moves came in 2024 and 2025: Cash & Equivalents jumped 305.89% in 2024, then slumped 89.14% in 2025.
• A 5-year view of Cash & Equivalents shows it stood at $125.7 million in 2022, then plunged by 65.8% to $43.0 million in 2023, then jumped by 140.92% to $103.6 million in 2024, then slumped by 62.53% to $38.8 million in 2025, then plunged by 64.98% to $13.6 million in 2026.
• The last three Cash & Equivalents figures came in at $13.6 million (Q1 2026), $38.8 million (Q4 2025), and $40.9 million (Q3 2025), per Business Quant data.